Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection
about
HIV infection and cardiovascular diseaseInflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort studyAssociation between chronic hepatitis C virus infection and low muscle mass in US adults.Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study.Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.HIV-associated lipodystrophy: impact of antiretroviral therapy.Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) studyThe effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques.Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat.A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational SettingsBody composition and metabolic changes in HIV-infected patientsManagement of the metabolic effects of HIV and HIV drugs.Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected AdultsLipolytic Rate Associated With Intramyocardial Lipid in an HIV Cohort Without Increased Lipolysis.Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV InfectionFunctional impairment is associated with low bone and muscle mass among persons aging with HIV infection.More than osteoporosis: age-specific issues in bone health.Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort StudyAssociation of the veterans aging cohort study index with exercise capacity in HIV-infected adults.Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women.Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected womenWeight and lean body mass change with antiretroviral initiation and impact on bone mineral density.Disease drivers of aging.Association of sarcopenic obesity with the risk of all-cause mortality: A meta-analysis of prospective cohort studies.Heart fat in HIV: marker or mediator of risk?Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.High prevalence of low skeletal muscle mass associated with male gender in midlife and older HIV-infected persons despite CD4 cell reconstitution and viral suppression.Cardiovascular risk and dyslipidemia among persons living with HIV: a review.Physical fitness characteristics of active duty US Air Force members with HIV infection.Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.Long-term body composition changes in antiretroviral-treated HIV-infected individuals.[Metabolic syndrome and cardiovascular diseases in HIV patients].Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women with and without HIV Infection.Endocrinological aspects of HIV infection.The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection.Surrogate markers of visceral adipose tissue in treated HIV-infected patients: accuracy of waist circumference determination.
P2860
Q27008915-CC159E4B-8B71-497E-920C-D37FB862EB6BQ28484274-9A44E430-0422-47D0-86FF-626B2C469FF8Q34536496-7D25E3FD-B0CA-4229-92DA-577EA5E53055Q34629756-03DBE6DD-4E04-474F-B52E-A6F774914C34Q34637395-E69D10EC-AE93-4C2D-9C25-8D74153EC7F6Q34655845-9502BC23-BBDD-455D-AD85-1C2CA056964BQ34766373-0C59C318-EC63-4D0C-9A9F-2A2F314937ACQ35060772-A937E27F-C0F5-409D-910B-B6529B6B9F47Q35410626-B6C0E478-3F6D-4E20-BFA9-858204C0445EQ35803315-071D5A96-7C07-47C2-B14D-4DDC97F665A2Q35881469-D279EB82-933F-4951-97CD-0C61A225B4E4Q35949965-0925F34E-BEA9-4346-869D-B20418F8784EQ36021411-19F2D4A5-C52A-406E-BC84-544C2A0F4EFAQ36208623-77626728-2ACB-4F90-B524-279A1F226F09Q36431659-5043C2C6-D1A4-4D04-AE93-2FFBBA3B0B1DQ36654972-DA9CA294-AA2A-452B-A7FF-3FA35998FF19Q36844115-4EE24EDE-0BCE-45BA-9A9C-D469651E449FQ36877351-B14949B3-DDAA-499A-A572-A0A5A5EDC18BQ37091664-4AE4D549-F8B4-4E55-9DB2-1EBED50BE821Q37111462-DDF837E9-4627-48D6-ABEA-A17012C509B4Q37433073-D6CEA175-25A6-4490-8150-B7586B13CC76Q37574064-9DEB23F9-452D-4EF6-AA7A-D7C9E8372C27Q37665151-5FCA1D36-E2CF-4BA9-8BA7-DADAF35D44A2Q37730342-6A11AFBD-0CC4-4F9F-BE91-C4B53FE10CB3Q38566137-87C290A5-13A3-4F61-B56D-F363EE2013A5Q38630822-92121748-4B57-407E-9DE8-8AA7AD1C37F8Q38741518-F39017E2-2965-4677-81FC-D9B0C4D44D95Q38936060-78F90EB2-10EA-4062-AA39-915138E19A17Q39344553-1796CFEB-569C-488C-BB8A-3763F92285EDQ40100018-FF1B4997-646B-4195-B160-E882B34DDDFBQ40446793-3E4326F9-6C8B-4820-BD12-79A605CA775AQ40503132-CE44651C-226A-491C-89F2-DB86F77A14D1Q40525805-4DCF37B9-8412-4046-8EA6-42C9C97B6DFEQ40529399-1CE94EBF-A016-448B-B29B-D3D33B02803BQ44862707-70B61F1E-9ED9-4049-BD9A-656A09F03A84Q45112147-C1A6423D-0C60-4F58-B367-0A066297F410Q46361539-7B320E8C-49ED-496A-88C6-404FA6BB2A5AQ47219853-E23AF411-A02B-4E15-A3F4-3A4C8A8D2DE6Q47891372-4556EA45-6FFB-4186-894B-64007545FF3CQ51153029-A3FA9E8A-4CA2-44AB-8C85-DBEBA468D684
P2860
Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Decreased limb muscle and incr ...... use mortality in HIV infection
@en
Decreased limb muscle and incr ...... se mortality in HIV infection.
@nl
type
label
Decreased limb muscle and incr ...... use mortality in HIV infection
@en
Decreased limb muscle and incr ...... se mortality in HIV infection.
@nl
prefLabel
Decreased limb muscle and incr ...... use mortality in HIV infection
@en
Decreased limb muscle and incr ...... se mortality in HIV infection.
@nl
P2093
P2860
P1433
P1476
Decreased limb muscle and incr ...... use mortality in HIV infection
@en
P2093
Carl Grunfeld
Daniel Lee
Peter Bacchetti
Phyllis C Tien
Rebecca Scherzer
Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)
William G Powderly
P2860
P304
P356
10.1097/QAD.0B013E32834884E6
P407
P577
2011-07-01T00:00:00Z